文献速递腹部MR

肝硬化患者Gd-EOB-DPTA增强MRI上不确定性肝细胞结节的演变

Evolution of indeterminate hepatocellular nodules at Gd-EOB-DPTA-enhanced MRI in cirrhotic patients.
PubMed 文献 · Radiol Med · 2018-03-15

回顾性分析33例肝硬化患者69个不确定性肝细胞结节(平均直径1.1 cm)在Gd-EOB-DPTA增强MRI随访至少2年中的演变,5/69个结节变为HCC。HCC病史、基线直径较大、体积增大及肝胆期低信号与HCC发生相关,其中体积增大和肝胆期低信号与HCC发生独立相关,但肝胆期低信号关联较弱。

要点

  • 肝硬化患者Gd-EOB-DPTA增强MRI上的不确定性肝细胞结节很少变为HCC(5/69)。
  • 随访中结节体积增大和肝胆期低信号与HCC发生相关。
  • 有HCC病史者结节变为HCC更常见。

核心结论

  • 肝硬化患者Gd-EOB-DPTA增强MRI上的不确定性肝细胞结节很少变为HCC;肝胆期低信号与HCC发生关联较弱。

研究设计与样本

  • 回顾性研究,纳入33例肝硬化患者69个不确定性肝细胞结节(平均直径1.1 cm),基线及随访Gd-EOB-DPTA增强MRI至少2年,由两名放射科医师评估结节大小和信号强度。

关键影像表现/征象

  • 随访中5/69个结节变为HCC,64/69个仍表现为不确定性特征。
  • HCC组结节基线直径显著大于无HCC组,且体积增大更显著。
  • HCC组肝胆期低信号显著多于无HCC组。

诊断标准与关键数值

  • 体积增大与HCC发生相关:OR 10.48,敏感度100%,特异度81.2%,p < 0.001。
  • 肝胆期低信号与HCC发生相关:OR 1.02,敏感度100%,特异度78.1%,p < 0.001。

临床应用与阅片要点

  • 随访中需关注结节体积增大及肝胆期低信号,二者与HCC发生相关。
  • 有HCC病史者结节变为HCC更常见,随访时应予以关注。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To retrospectively analyze the evolution of indeterminate hepatocellular nodules in cirrhotic patients on serial Gd-EOB-DPTA-enhanced MRI, and to identify predictors of HCC development.

MATERIALS AND METHODS: This IRB approved study included 33 cirrhotic patients with 69 indeterminate hepatocellular nodules (mean diameter 1.1 cm) at baseline Gd-EOB-DPTA-enhanced MRI and a Gd-EOB-DPTA-enhanced-MRI follow-up of at least 2 years. Two radiologists evaluated size and signal intensity of each nodule at baseline and follow-up. Age, cirrhosis etiology, and HCC history were recorded. Data were compared between nodules that became HCCs at follow-up (HCC) and those that did not (no-HCC).

RESULTS: On follow-up, 5/69 nodules became HCCs and 64/69 showed indeterminate characteristics. HCC history was more frequently found in HCCs than in no-HCCs. Age, sex, and cirrhosis etiology were not significantly different between HCCs and no-HCCs. HCCs had a significantly greater baseline diameter and increase in size than no-HCCs. Hepatobiliary phase hypointensity was significantly more common in HCCs than in no-HCCs. Multivariate regression analysis showed that increase in size (OR 10.48; sensitivity, 100%; specificity, 81.2%; p < 0.001) and hepatobiliary phase hypointensity (OR 1.02; sensitivity, 100%; specificity, 78.1%; p < 0.001) was associated with HCC development.

CONCLUSION: Indeterminate hepatocellular nodules at Gd-EOB-DPTA-enhanced MRI in cirrhotic patients rarely became HCCs. Hepatobiliary phase hypointensity had a weak association with HCC development.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Galia M, Agnello F, Sparacia G, et al. Evolution of indeterminate hepatocellular nodules at Gd-EOB-DPTA-enhanced MRI in cirrhotic patients. Radiol Med. 2018. PMID: 29546493. doi:10.1007/s11547-018-0873-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。